Effect of a rituximab-based regimen on the incidence of CNS relapse in patients with diffuse large B-cell lymphoma.
2010
8098 Background: CNS relapse following initial treatment of DLBCL is an uncommon but fatal complication. The addition of rituximab improves the clinical outcome dramatically, but its influence on C...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI